Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways.
Biomed Pharmacother
; 141: 111874, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34229251
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biphenyl Compounds
/
NF-kappa B
/
Mitogen-Activated Protein Kinase Kinases
/
Protein Kinase Inhibitors
/
Diet, High-Fat
/
Non-alcoholic Fatty Liver Disease
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Biomed Pharmacother
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: